about
Autophagy and its link to type II diabetes mellitusSustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity/type 2 diabetesCould the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?Polymer-based delivery of glucagon-like Peptide-1 for the treatment of diabetes.AAV-mediated gene therapy for atherosclerosis.Engineered Epidermal Progenitor Cells Can Correct Diet-Induced Obesity and Diabetes.
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Glucagon-like peptide-1 gene therapy
@ast
Glucagon-like peptide-1 gene therapy
@en
type
label
Glucagon-like peptide-1 gene therapy
@ast
Glucagon-like peptide-1 gene therapy
@en
prefLabel
Glucagon-like peptide-1 gene therapy
@ast
Glucagon-like peptide-1 gene therapy
@en
P2093
P2860
P921
P356
P1476
Glucagon-like peptide-1 gene therapy
@en
P2093
Anne M Rowzee
Giovanni Di Pasquale
John A Chiorini
Niamh X Cawley
P2860
P304
P356
10.1155/2011/601047
P5008
P577
2011-06-20T00:00:00Z